Login to Your Account



Bench Press: BioWorld Looks at Translational Medicine


Wednesday, December 26, 2012
Researchers at Duke University and the National Institutes of Health have intravenously administered bispecific T-cell engager antibodies, or BiTEs, to improve the survival of mice with brain tumors.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription